Alexander (“Alex”) is a member of the firm’s Patent Prosecution & Litigation group, with a focus on life sciences and biotechnology patent litigation. Alexander received his J.D. from Vanderbilt University in May 2023. During law school, he clerked for several firms and worked in-house at a large tech insurance company, gaining experience in drafting patent opinions, utility and design patent claims and applications, reviewing possible infringement claims, and managing patent portfolios and other intellectual property matters.

Prior to attending law school, Alexander worked as an intern research scientist for a Fortune 500 pharmaceutical company, focusing on oncology target-validation research and CRISPR technologies. He has also presented research at annual meetings for both the Tennessee Academy of Science and the Association of Southeastern Biologists. 

Thought Leadership

  • “Why Punish Pharma for Making Medicine? Preserving Patent Protections and Cutting Consumer Costs,” 25 Vand. J. Ent. & Tech L. 603 (2023)